Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.27, up 1.35% from the previous day, outperforming the S&P 500. Analysts expect earnings of -$2.80 per share with a revenue of $43.92 million. Zacks Consensus Estimates predict -$12.60 EPS and $182.13 million revenue for the full year. The Zacks Rank for DNA is currently a Hold (#3).

The Medical sector’s Biomedical and Genetics industry, which includes DNA, has a Zacks Industry Rank of 75, placing it in the top 30% of industries. Utilize Zacks.com to track DNA’s performance. Zacks offers a 30-day access to all picks for only $1, featuring services like Surprise Trader, Stocks Under $10, and Technology Innovators with impressive gains in 2023.

Zacks Investment Research provides valuable insights on Ginkgo Bioworks Holdings, Inc. (DNA) and other stocks. Gain access to free stock analysis, recommendations, and more on Zacks.com. Explore the latest news and updates on DNA’s performance in the stock market.

Read more at Nasdaq: Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know